Elderly men with prostate cancer had markedly lowered sphingomyelin.
Plasma choline and phosphatidylcholine were similar to elderly with hyperplasia.
Plasma phosphatidylcholine was a strong positive predictor of sphingomyelin.
Statins lowered plasma sphingomyelin, similar to the presence of prostate cancer.